|
Mental perception of prostate cancer (PCa) disease in patients aged 60 years and older initiating gonadotropin-releasing hormone agonist (GnRHa) therapy. |
|
|
Consulting or Advisory Role - Amgen; Astellas Oncology; Bouchara Recordati; Ipsen; Janssen; Roche |
Research Funding - AstraZeneca; Roche |
Travel, Accommodations, Expenses - Ipsen; Janssen |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; Ferring; Janssen-Cilag |
Travel, Accommodations, Expenses - Astellas Oncology; Bouchara Recordati; Ferring; Janssen-Cilag |
|
Nathalie Pello Leprince Ringuet |
|
Stock and Other Ownership Interests - Ipsen |
Other Relationship - Ipsen |
|
|
|
Stock and Other Ownership Interests - Ipsen |
|
|
Consulting or Advisory Role - Astellas Pharma; GlaxoSmithKline; GlaxoSmithKline; Intuitive Surgical; Ipsen; Janssen-Cilag; Lilly; Roche; Sanofi; Takeda |
Travel, Accommodations, Expenses - Astellas Pharma; Coloplast |